Green's Child and Adolescent Clinical Psychopharmacology

by ; ; ;
  • ISBN13:


  • ISBN10:


  • Edition: 5th
  • Format: Paperback
  • Copyright: 10/17/2013
  • Publisher: LWW
  • Purchase Benefits
  • Free Shipping On Orders Over $59!
    Your order must be $59 or more to qualify for free economy shipping. Bulk sales, PO's, Marketplace items, eBooks and apparel do not qualify for this offer.
  • Get Rewarded for Ordering Your Textbooks! Enroll Now
List Price: $113.05 Save up to $3.39
  • Buy New
    Add to Cart Free Shipping


Supplemental Materials

What is included with this book?

  • The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
  • The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.


 The ideal quick reference for the busy mental health clinician seeing younger patients, the Fifth Edition of Green’s Child and Adolescent Clinical Psychopathology has been fully revised by a new team of authors active in clinical practice and resident education.  A trusted reference in the field, Green’s continues to provide practical and balanced information on the full range of medications used to treat mental health disorders in children and adolescents.

 This rapid reference delivers…
• Detailed coverage of medication usage—including both FDA-approved and evidence-based off-label uses.
• Precautions and warnings help readers avoid prescribing errors and adverse drug interactions.
• Emphasis on recent and highly used medications, with older and less often used agents grouped in an Appendix.
• Convenient, reader-friendly organization makes essential information easy to find and use.

 NEW to the Fifth Edition…
• Increased focus on medication effects and cost-effectiveness
• New information on cardiac function and risk factors in patients taking stimulants
• Long-term suicide risks associated with SSRIs
• Longer term outcomes of major depression treatment
• Use of anticonvulsant medications in patients with bipolar disorder
• Weight gain in patients taking antipsychotics

Rewards Program

Write a Review